Concomitant Radiotherapy and Paclitaxel for High-Risk Endometrial Cancer: First Feasibility Study
- 30 April 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (1) , 53-57
- https://doi.org/10.1006/gyno.2000.6088
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Stage IVB Endometrial Carcinoma: The Role of Cytoreductive Surgery and Determinants of SurvivalGynecologic Oncology, 2000
- Endometrial cancerCurrent Opinion in Oncology, 1999
- Persistent Chemosensitivity to Platinum and/or Paclitaxel in Metastatic Endometrial CancerGynecologic Oncology, 1999
- External pelvic radiation therapy in stage IC endometrial carcinomaPublished by Wolters Kluwer Health ,1999
- Endometrial Neoplasia: Prognostic Significance of Ploidy StatusClinical Obstetrics and Gynecology, 1996
- Paclitaxel sensitizes multidrug resistant cells to radiationAnti-Cancer Drugs, 1996
- Endometrial Carcinoma—Relative Effectiveness of Adjuvant Irradiation vs Therapy Reserved for RelapseGynecologic Oncology, 1996
- Postoperative Adjuvant Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) Chemotherapy in Women with High-Risk Endometrial CarcinomaGynecologic Oncology, 1994
- Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgeryGynecologic Oncology, 1992
- Prognostic factors and sites of failure in figo Stage I, Grade 3 endometrial carcinomaGynecologic Oncology, 1987